Suppr超能文献

转录因子 Hoxb5 将 B 细胞重编程为功能性 T 淋巴细胞。

Transcription factor Hoxb5 reprograms B cells into functional T lymphocytes.

机构信息

CAS Key Laboratory of Regenerative Biology and Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.

University of Chinese Academy of Sciences, Beijing, China.

出版信息

Nat Immunol. 2018 Mar;19(3):279-290. doi: 10.1038/s41590-018-0046-x. Epub 2018 Feb 12.

Abstract

Deletion of master regulators of the B cell lineage reprograms B cells into T cells. Here we found that the transcription factor Hoxb5, which is expressed in uncommitted hematopoietic progenitor cells but is not present in cells committed to the B cell or T cell lineage, was able to reprogram pro-pre-B cells into functional early T cell lineage progenitors. This reprogramming started in the bone marrow and was completed in the thymus and gave rise to T lymphocytes with transcriptomes, hierarchical differentiation, tissue distribution and immunological functions that closely resembled those of their natural counterparts. Hoxb5 repressed B cell 'master genes', activated regulators of T cells and regulated crucial chromatin modifiers in pro-pre-B cells and ultimately drove the B cell fate-to-T cell fate conversion. Our results provide a de novo paradigm for the generation of functional T cells through reprogramming in vivo.

摘要

缺失 B 细胞谱系的主调控因子可将 B 细胞重编程为 T 细胞。在这里,我们发现转录因子 Hoxb5 可将前 B 祖细胞重编程为功能性早期 T 细胞谱系祖细胞,该因子在未定向造血祖细胞中表达,但不存在于定向 B 细胞或 T 细胞谱系的细胞中。这种重编程始于骨髓,并在胸腺中完成,产生的 T 淋巴细胞具有转录组、层次分化、组织分布和免疫学功能,与天然 T 淋巴细胞非常相似。Hoxb5 抑制 B 细胞“主基因”,激活 T 细胞调控因子,并调控前 B 祖细胞中的关键染色质修饰因子,最终驱动 B 细胞命运向 T 细胞命运转变。我们的研究结果为体内重编程生成功能性 T 细胞提供了一个新的范例。

相似文献

9
Reprogramming of B cells.B细胞重编程
Methods Mol Biol. 2010;636:233-50. doi: 10.1007/978-1-60761-691-7_15.

引用本文的文献

8
T cell regeneration: an update on progress and challenges.T细胞再生:进展与挑战的最新情况
Blood Sci. 2020 Jan 16;2(1):22-26. doi: 10.1097/BS9.0000000000000037. eCollection 2020 Jan.
10
Cell Fate Reprogramming in the Era of Cancer Immunotherapy.癌症免疫治疗时代的细胞命运重编程。
Front Immunol. 2021 Jul 21;12:714822. doi: 10.3389/fimmu.2021.714822. eCollection 2021.

本文引用的文献

3
MLL1 Inhibition Reprograms Epiblast Stem Cells to Naive Pluripotency.MLL1抑制将上胚层干细胞重编程为原始多能性。
Cell Stem Cell. 2016 Apr 7;18(4):481-94. doi: 10.1016/j.stem.2016.02.004. Epub 2016 Mar 17.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验